We constructed a three-state Markov model to estimate costs, quality-adjusted life-years (QALYs), incremental net monetary benefit (INMB), and incremental cost-effectiveness ratios (ICERs) in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results